Submissions for variant NM_001854.4(COL11A1):c.4381A>G (p.Ile1461Val)

dbSNP: rs2100858136

Total submissions: 1

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Labcorp Genetics (formerly Invitae), Labcorp	RCV001872889	SCV002143178	uncertain significance	not provided	2021-10-20	criteria provided, single submitter	clinical testing	This sequence change replaces isoleucine with valine at codon 1461 of the COL11A1 protein (p.Ile1461Val). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and valine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL11A1 protein function. This variant has not been reported in the literature in individuals affected with COL11A1-related conditions. This variant is not present in population databases (ExAC no frequency).